Search details
1.
Circulating tumour DNA dynamics during alternating chemotherapy and hormonal therapy in metastatic breast cancer: the ALERT study.
Breast Cancer Res Treat
; 2024 Apr 06.
Article
in English
| MEDLINE | ID: mdl-38581534
2.
The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDS.
Respir Res
; 25(1): 151, 2024 Apr 01.
Article
in English
| MEDLINE | ID: mdl-38561798
3.
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.
Mol Cancer
; 22(1): 138, 2023 08 18.
Article
in English
| MEDLINE | ID: mdl-37596643
4.
The Inhibitory Properties of a Novel, Selective LMTK3 Kinase Inhibitor.
Int J Mol Sci
; 24(1)2023 Jan 03.
Article
in English
| MEDLINE | ID: mdl-36614307
5.
Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation.
Oncologist
; 27(7): e561-e570, 2022 07 05.
Article
in English
| MEDLINE | ID: mdl-35278078
6.
Novel immunotherapeutic drugs for the treatment of lung cancer.
Curr Opin Oncol
; 34(1): 89-94, 2022 Jan 01.
Article
in English
| MEDLINE | ID: mdl-34636350
7.
Radiation recall pneumonitis triggered by an immune checkpoint inhibitor following re-irradiation in a lung cancer patient: a case report.
BMC Pulm Med
; 22(1): 54, 2022 Feb 05.
Article
in English
| MEDLINE | ID: mdl-35123465
8.
Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19.
J Allergy Clin Immunol
; 147(1): 107-111, 2021 01.
Article
in English
| MEDLINE | ID: mdl-32920092
9.
Profiling circulating tumour cells and cell free DNA together in metastatic colon cancer.
Br J Cancer
; 125(7): 907-908, 2021 09.
Article
in English
| MEDLINE | ID: mdl-33953346
10.
Circulating MicroRNAs in Small-bowel Neuroendocrine Tumors: A Potential Tool for Diagnosis and Assessment of Effectiveness of Surgical Resection.
Ann Surg
; 274(1): e1-e9, 2021 07 01.
Article
in English
| MEDLINE | ID: mdl-31373926
11.
Long-term efficacy and safety of CT-P6 versus trastuzumab in patients with HER2-positive early breast cancer: final results from a randomized phase III trial.
Breast Cancer Res Treat
; 188(3): 631-640, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-34148205
12.
Comparison of two targeted ultra-deep sequencing technologies for analysis of plasma circulating tumour DNA in endocrine-therapy-resistant breast cancer patients.
Breast Cancer Res Treat
; 188(2): 465-476, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-34097174
13.
SSB1/SSB2 Proteins Safeguard B Cell Development by Protecting the Genomes of B Cell Precursors.
J Immunol
; 202(12): 3423-3433, 2019 06 15.
Article
in English
| MEDLINE | ID: mdl-31085591
14.
Lessons to Europe from China for cancer treatment during the COVID-19 pandemic.
Br J Cancer
; 123(1): 7-8, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32409750
15.
Patient-derived xenograft models-the future of personalised cancer treatment.
Br J Cancer
; 122(5): 601-602, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31919403
16.
JAK Inhibitors - More Than Just Glucocorticoids.
N Engl J Med
; 385(5): 463-465, 2021 07 29.
Article
in English
| MEDLINE | ID: mdl-34320294
17.
TP53 regulates miRNA association with AGO2 to remodel the miRNA-mRNA interaction network.
Genome Res
; 26(3): 331-41, 2016 Mar.
Article
in English
| MEDLINE | ID: mdl-26701625
18.
Sustained expression of miR-26a promotes chromosomal instability and tumorigenesis through regulation of CHFR.
Nucleic Acids Res
; 45(8): 4401-4412, 2017 05 05.
Article
in English
| MEDLINE | ID: mdl-28126920
19.
Shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastoma.
Mol Cancer
; 17(1): 132, 2018 08 31.
Article
in English
| MEDLINE | ID: mdl-30165850
20.
miR-515-5p controls cancer cell migration through MARK4 regulation.
EMBO Rep
; 17(4): 570-84, 2016 04.
Article
in English
| MEDLINE | ID: mdl-26882547